Building on many years of partnership, Zuellig Pharma Taiwan and Taiko Pharmaceutical Limited have kicked off a new collaboration that will see Zuellig Pharma distribute and promote Cleverin in Taiwan.
Cleverin® is a leading Japanese environmental decontamination technology, and has been listed by the US Centers for Disease Control and Prevention and Occupational Safety and Health Administration as an effective disinfectant for healthcare organization and household use. The brand sells approximately 10 million bottles in Japan every year.
Zuellig Pharma Taiwan Chief Executive John Chou said: “Cleverin® is an innovative environmental decontaminant technology to prevent infectants spreading at home. We are proud to work with Taiko Pharmaceutical to help them make this technology available in the Taiwan market.” As part of the promotional strategy, Zuellig Pharma Taiwan organized for Taiko Pharmaceutical President Dr. Takashi Shibata to give a presentation at the Greater Taipei Area Hospital and the Densely Populated Organization Infection Control Seminar.
“Dr. Shibata was invited to speak as an expert in chlorine dioxide gas technology and the experience the company has had in Japan with this technology,” Mr. Chou said. “The events were attended by Minister of Health and Welfare Dr. Lin Tzou-yien, and more than 800 healthcare professionals. It was therefore a great opportunity for us to raise awareness of Taiko Pharmaceutical and its expertise in this category among Taiwan’s medical community.”
